AbbVie Inc.
INHIBITORS OF TYROSINE KINASE 2 MEDIATED SIGNALING

Abstract:

Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4a, R.sup.4b, X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.5, and n are as defined herein, pharmaceutical compositions comprising same, and methods of preparation and use. ##STR00001##